47
Participants
Start Date
December 31, 2010
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
C-10276
C-10276 200 mg, C-10276 400 mg, Reyataz 400 mg oral, single dose
C-10276
C-10276 300 mg, CTP-518 100 mg with C-10276 300 mg, C-10276 400 mg oral, single dose
C-10297
C-10297 200 mg, oral, single dose
C-10299
C-10299 200 mg, oral, single dose
C-10297
C-10297 400 mg, Reyataz 400 mg, C-10297 600 mg, oral, single dose
C-10299
C-10299 400 mg, Reyataz 400 mg, C-10299 600 mg, oral, single dose
C-10276
C-10276 600 mg, Reyataz 400 mg, Reyataz 600 mg, oral, single dose
Reyataz®
Reyataz 400 mg, oral, single dose Reyataz 600 mg, oral, single dose
Lead Sponsor
Concert Pharmaceuticals
INDUSTRY